Picture of Sartorius Stedim Biotech SA logo

DIM Sartorius Stedim Biotech SA Income Statement

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Annual income statement for Sartorius Stedim Biotech SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

R2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,4411,9102,8873,4932,776
Cost of Revenue
Gross Profit7481,0031,5531,8351,234
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1,1091,4382,0222,4982,327
Operating Profit332472865995449
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes3174616471,130401
Provision for Income Taxes
Net Income After Taxes236339414880312
Minority Interest
Net Income Before Extraordinary Items
Net Income235336414876310
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income235336414876310
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS2.823.94.689.94.32
Dividends per Share